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Recent work has linked specific genetic variation
found in human populations to risk for developing
neuropsychiatric diseases. How that risk is mediated
through molecular-, cellular- and systems-level
mechanisms now becomes the central question in this
field. Two recent papers studying high-penetrance copy
number variation at chromosome 16p11.2 find large
changes in brain structure, refining hypotheses about
the regions of the brain that are affected and implicating
specific neurodevelopmental processes in these
changes.The long road
Research in the field of genetics has identified many
types of genetic variation - from single base-pair changes
to large chromosomal deletions and duplications - that
have a statistical association with increased risk for a dis-
ease. These are a huge boon, especially to neuropsychi-
atric research, suggesting a causal basis for many of
these disorders for the first time. But identification of a
risk variant is just the first step; genetic variants exert
their effects at molecular, cellular, circuit and systems
levels to alter the function of the brain, which can then
manifest as an illness. Variant functionality is largely
unexplored and is the next great frontier in human genet-
ics research. The hope is that by disentangling a variant’s
biological consequences, we may be able to interfere with
its downstream effects to develop therapeutic treat-
ments that adjust dysfunctional biochemical pathways.
However, it is a long road from identifying genetic risk
variants to a mechanistic understanding of a neuro-
psychiatric disease.
One of the mutational classes that contribute to neurode-
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plications of chromosomes. What is striking is that at cer-
tain spots in the genome, CNVs are found significantly
more frequently in patients with neuropsychiatric disease
than in controls. One particular locus, at chromosome
16p11.2, has been strongly associated with a variety of
neuropsychiatric phenotypes, and the attempt to elu-
cidate the biological consequences of variations at this
locus is now beginning. Two recent studies have ana-
lyzed the effects of 16p11.2 variants on brain anatomy
and have shed light on the processes that may lead to
disease [1,2].The 16p11.2 variant
Copy number changes at 16p11.2 are rare in people with
neuropsychiatric diseases and even rarer in healthy
populations (duplication and deletion rates in healthy
populations are approximately 0.04% [3,4]). When these
mutations do occur, they increase risk for a wide variety
of disorders, including autism spectrum disorder (ASD),
schizophrenia, developmental delay, epilepsy and obesity
[3-7]. The mutations are not fully penetrant; that is, not
everyone with a mutation will also have the disease [4].
However, people with 16p11.2 deletions have an approxi-
mately nine times greater likelihood of developing ASD,
but no appreciable increase in risk for schizophrenia;
those with the duplication have a nine times greater like-
lihood of developing both ASD and schizophrenia [3].
Variation at this genomic region thus represents a clear
risk factor for a range of neuropsychiatric disorders and
provides insight into their molecular basis. The functional
effects of such variations are not limited to neuropsychi-
atric phenotypes: 16p11.2 deletion carriers are much more
likely to be overweight, whereas duplication carriers are
more likely to be underweight [6].
The large genomic region either deleted or duplicated
in these CNVs at 16p11.2 spans 29 genes. Molecularly,
gene expression within the CNV has been shown to fol-
low the cardinality of the mutation [6,8]; that is, peoplean Open Access article distributed under the terms of the Creative Commons
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carriers have decreased expression of genes within the
region. Interestingly, the expression of genes outside the
region is also affected and those genes are often involved
in synaptic function, chromatin modification, or are
other known ASD risk genes [8]. This implies a shared
mechanism at the molecular level across different etiolo-
gies of ASD.
The anatomy of a CNV
Given the neuropsychiatric risk and previously identified
associations with head circumference [6], a clear next
step is to determine if and how brain structure, as mea-
sured through magnetic resonance imaging (MRI), is
affected in patients carrying 16p11.2 CNVs. Because this
is a rare variant with high penetrance, it is useful for the
study of known broad-spectrum disease phenotypes in
relatively small sample sizes and in largely control po-
pulations; in turn, this has the advantage of enabling
researchers to investigate the effect of the variation with-
out their results being confounded by differences in
medication or the altered environment of a patient. Two
studies [1,2] have recently measured macro-scale brain
structure via MRI in individuals with 16p11.2 deletion
(N = 27, N = 14, respectively) and duplication (N = 17,
N = 17, respectively), most of whom had not been diag-
nosed with either schizophrenia or ASD. Given the rarity
of the mutation and the hypothesized large effects on the
brain, these should be considered relatively large sample
sizes.
Both studies find large global differences in intracra-
nial volume and total white and gray matter volumes;
deletion carriers have larger volumes and duplication
carriers have smaller volumes relative to controls. Both
studies find an effect in the same direction on cortical
surface area, but less evidence is found for alterations in
cortical thickness. This dichotomy is consistent with a
developmental change in the formation of the brain. The
radial unit hypothesis predicts that this type of abnor-
mality in cortical surface area could be due to a greater
number of neural progenitors being produced during
fetal development in deletion carriers, which then differ-
entiate to create a cortical plate with a larger surface
area [9]. The replicable findings of high effect across two
cohorts give strong support to this developmental mech-
anism. In addition, these studies identify a phenotype
that stem cell or animal models of the 16p11.2 mutation
can attempt to replicate, and subsequently to correct
through drug screening.
When studying chromosomal effects on the structure
of specific brain regions, the picture becomes more
complicated. One of the strongest findings was an effect
on thalamic volume, which was greater in deletion car-
riers and smaller in duplication carriers in both studies,even after controlling for a global measure of head size
(intracranial volume). Overall cerebellar volume showed
the same relationship in one study [1], but specific regions
of the cerebellum were found to have the opposite direc-
tion of effect in the other [2]. The volume of regions of
the striatum had the same relationship with carrier status
as thalamic volume in one study [2], but this was not sig-
nificantly replicated in the other study [1]. Regional, rather
than global, thickness and area in specific cortical areas
were not evaluated in one study [1], so it is currently not
possible to assess the reproducibility of this phenotype. It
should be noted that differences in the method of analysis,
age of participants and genetic variation outside the
16p11.2 region, and within the region in an unaffected
chromosome, could be responsible for the different results
seen across the cohorts in the two studies. Obtaining a
clearer picture of the specific regions affected in patients
will take larger cohorts.Further down the road
These two studies are an excellent example of collab-
orative consortium-based science at work. Because
16p11.2 mutations are so rare, organizations such as
the Simons Variations in Individuals Project and the
16p11.2 European Consortium aggregate individuals from
many sites around the world to acquire enough subjects
to obtain the statistical power to perform analyses like
these. This collaborative framework allows the discovery
of novel insights into rare genetic influences on brain
structure and how they lead to disease. Similar efforts
like the Enhancing Neuroimaging Genetics through
Meta-analysis (ENIGMA) consortium [10] are revealing
how common variants affect brain structure, and may also
lead to increases in mechanistic understanding about the
links from genes to brains to disease, and everything in
between. It is also critical that, given how resource inten-
sive imaging studies on genetically defined cohorts are,
they should be performed in such a way that the data be
easily shared and analyzed by other investigators with
minimal burden. This has not been the standard of prac-
tice in neuroimaging, as it is in genomics and genetics,
but the differing findings in the two studies discussed here
emphasize how useful this would be. Ultimately, such
studies may help to delineate how genetic variation leads
to neuropsychiatric diseases through alterations in brain
structure.Abbreviations
ASD: Autism spectrum disorders; CNV: Copy number variation;
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